BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26506877)

  • 21. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Controversies in the management of locoregionally advanced nasopharyngeal carcinoma.
    Chan AT; Teo PM; Johnson PJ
    Curr Opin Oncol; 1998 May; 10(3):219-25. PubMed ID: 9619358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A phase I/II study of neoadjuvant chemotherapy followed by radiation with boost chemotherapy for advanced T-stage nasopharyngeal carcinoma.
    Johnson FM; Garden AS; Palmer JL; Shin DM; Morrison W; Papadimitrakopoulou V; Khuri F; Clayman G; Goepfert H; Ang KK; Hong WK; Glisson BS
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):717-24. PubMed ID: 16199307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Role of Neoadjuvant Chemotherapy in the Treatment of Nasopharyngeal Carcinoma: A Multi-institutional Retrospective Study (KROG 11-06) Using Propensity Score Matching Analysis.
    Song JH; Wu HG; Keam BS; Hah JH; Ahn YC; Oh D; Noh JM; Park HJ; Lee CG; Keum KC; Cha J; Cho KH; Moon SH; Kim JY; Chung WK; Oh YT; Kim WT; Cho MJ; Kay CS; Kim YS
    Cancer Res Treat; 2016 Jul; 48(3):917-27. PubMed ID: 26727716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metronidazole amino acidum natrium combined with radiation in the treatment of nasopharyngeal carcinoma: A meta-analysis based on randomized controlled trials.
    Wei S; Xing Y; Liu J; Wang L; Yang X; Song F; Yang C; Niu L; Yang Y; Wu F
    J Cancer Res Ther; 2015 Oct; 11 Suppl 2():C222-5. PubMed ID: 26506881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy with or without adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: meta-analysis of 1,096 patients from 11 randomized controlled trials.
    Liang ZG; Zhu XD; Tan AH; Jiang YM; Qu S; Su F; Xu GZ
    Asian Pac J Cancer Prev; 2013; 14(1):515-21. PubMed ID: 23534786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type.
    Azli N; Fandi A; Bachouchi M; Rahal M; Lianes P; Wibault P; Boussen H; Eschwege F; Armand JP; Cvitkovic E
    Cancer J Sci Am; 1995; 1(3):222-9. PubMed ID: 9166480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma.
    Chan AT; Teo PM; Leung TW; Leung SF; Lee WY; Yeo W; Choi PH; Johnson PJ
    Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):569-77. PubMed ID: 7558945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of adjuvant chemotherapy in nasopharyngeal carcinoma with bulky neck lymph nodes in the era of IMRT.
    Xu T; Shen C; Ou X; He X; Ying H; Hu C
    Oncotarget; 2016 Apr; 7(15):21013-22. PubMed ID: 26942700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of lobaplatin combined with 5-fluorouracil as first-line induction chemotherapy followed by lobaplatin-radiotherapy in locally advanced nasopharyngeal carcinoma: preliminary results of a prospective phase II trial.
    Ke LR; Xia WX; Qiu WZ; Huang XJ; Yang J; Yu YH; Liang H; Liu GY; Ye YF; Xiang YQ; Guo X; Lv X
    BMC Cancer; 2017 Feb; 17(1):134. PubMed ID: 28202000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemoradiotherapy with weekly low-dose docetaxel and cisplatin concurrent with radiation for patients with locally advanced nasopharyngeal carcinoma, followed by adjuvant chemotherapy for selected patients.
    Nakahara S; Hanamoto A; Seo Y; Miyaguchi S; Yamamoto Y; Tomiyama Y; Yoshii T; Takenaka Y; Yoshioka Y; Isohashi F; Ogawa K; Inohara H
    Jpn J Clin Oncol; 2016 Oct; 46(10):903-910. PubMed ID: 27474126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of induction chemotherapy with vinorelbine plus cisplatin (NP) or docetaxel plus cisplatin (TP) combined with concurrent chemoradiotherapy for patients with locally advanced nasopharyngeal carcinoma].
    Han SH; Yu L; Zhang Z; Zhang PJ; Song HP; Guo CY
    Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):623-6. PubMed ID: 24314223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis.
    Blanchard P; Lee A; Marguet S; Leclercq J; Ng WT; Ma J; Chan AT; Huang PY; Benhamou E; Zhu G; Chua DT; Chen Y; Mai HQ; Kwong DL; Cheah SL; Moon J; Tung Y; Chi KH; Fountzilas G; Zhang L; Hui EP; Lu TX; Bourhis J; Pignon JP;
    Lancet Oncol; 2015 Jun; 16(6):645-55. PubMed ID: 25957714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemotherapy in advanced nasopharyngeal cancer.
    Ali H; al-Sarraf M
    Oncology (Williston Park); 2000 Aug; 14(8):1223-30; discussion 1232-7, 1239-42. PubMed ID: 10989829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of Chemotherapy in Stage II Nasopharyngeal Carcinoma Treated with Curative Radiotherapy.
    Kang MK; Oh D; Cho KH; Moon SH; Wu HG; Heo DS; Ahn YC; Park K; Park HJ; Park JS; Keum KC; Cha J; Kim JW; Kim YS; Kang JH; Oh YT; Kim JY; Kim SH; Kim JH; Lee CG
    Cancer Res Treat; 2015 Oct; 47(4):871-8. PubMed ID: 25687858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neo-adjuvant Docetaxel and Cisplatin followed by concurrent Cisplatin with radiation therapy in treatment of locally advanced nasopharyngeal carcinoma.
    Hassan E; Galal K; Esmat E
    Gulf J Oncolog; 2008 Jan; (3):46-53. PubMed ID: 20084797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment outcomes for radiotherapy alone are comparable with neoadjuvant chemotherapy followed by radiotherapy in early-stage nasopharyngeal carcinoma.
    Song CH; Wu HG; Heo DS; Kim KH; Sung MW; Park CI
    Laryngoscope; 2008 Apr; 118(4):663-70. PubMed ID: 18216741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in nasopharyngeal carcinoma.
    O'Meara WP; Lee N
    Curr Opin Oncol; 2005 May; 17(3):225-30. PubMed ID: 15818165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction chemotherapy with carboplatin and taxol followed by radiotherapy and concurrent weekly carboplatin + taxol in locally advanced nasopharyngeal carcinoma.
    Airoldi M; Gabriele P; Gabriele AM; Garzaro M; Raimondo L; Pedani F; Beatrice F; Pecorari G; Giordano C
    Cancer Chemother Pharmacol; 2011 May; 67(5):1027-34. PubMed ID: 20644931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined chemoradiation versus radiation therapy alone in locally advanced nasopharyngeal carcinoma: results of a meta-analysis of 1,528 patients from six randomized trials.
    Huncharek M; Kupelnick B
    Am J Clin Oncol; 2002 Jun; 25(3):219-23. PubMed ID: 12040275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.